Building a monitoring matrix for the management of multiple sclerosis

I Voigt, H Inojosa, J Wenk, K Akgün, T Ziemssen - Autoimmunity Reviews, 2023 - Elsevier
Multiple sclerosis (MS) has a longitudinal and heterogeneous course, with an increasing
number of therapy options and associated risk profiles, leading to a constant increase in the …

Building digital patient pathways for the management and treatment of multiple sclerosis

J Wenk, I Voigt, H Inojosa, H Schlieter… - Frontiers in …, 2024 - frontiersin.org
Recent advances in the field of artificial intelligence (AI) could yield new insights into the
potential causes of multiple sclerosis (MS) and factors influencing its course as the use of AI …

Scoping review of clinical decision support systems for multiple sclerosis management: Leveraging information technology and massive health data

S Demuth, C Ed‐Driouch, C Dumas… - European Journal of …, 2024 - Wiley Online Library
Background and purpose Multiple sclerosis (MS) is a complex autoimmune disease of the
central nervous system, with numerous therapeutic options, but a lack of biomarkers to …

[HTML][HTML] Вторично-прогрессирующий рассеянный склероз: новые подходы к диагностике и терапии

НН Спирин, ДС Касаткин, МД Матсон… - Нервные …, 2022 - cyberleninka.ru
Вторично-прогрессирующий рассеянный склероз (ВПРС) является одной из важных
проблем неврологии. В статье изложены современные взгляды на постановку …

Swept-Source Optical Coherence Tomography Thresholds in Differentiating Clinical Outcomes in a Real-World Cohort of Treatment-Naïve Multiple Sclerosis Patients

Ł Rzepiński, J Kucharczuk, M Tkaczyńska, V Parisi… - Brain Sciences, 2023 - mdpi.com
This study aimed to determine whether peripapillary retinal nerve fiber layer (pRNFL) and
ganglion cell–inner plexiform layer (GCIPL) thickness thresholds for single-time-point swept …

Socioeconomic factors in multiple sclerosis

HØ Flemmen - 2023 - duo.uio.no
The overall aim of this project was to evaluate the impact of socioeconomic factors on
different aspects of multiple sclerosis (MS). There is substantial evidence that individuals …

Kognitivne promjene u pacijenata sa multiplom sklerozom

T Hercog - 2023 - repozitorij.svkst.unist.hr
Ciljevi istraživanja: Prikazati kognitivne promjene u novodijagnosticiranih ispitanika sa
multiplom sklerozom u Klinici za neurologiju KBC-a Split. Također, objasniti najlošije …

Disease Activity and Progression in Multiple Sclerosis: New Evidences and Future Perspectives

I Del Negro, S Pez, GL Gigli, M Valente - Journal of Clinical Medicine, 2022 - mdpi.com
Multiple sclerosis (MS) is a chronic, debilitating, autoimmune-mediated, inflammatory
disease of the central nervous system (CNS), in which a combination of inflammation …